Zobrazeno 1 - 10
of 92
pro vyhledávání: '"C. Guerois"'
Autor:
A. Rafowicz, S Donadel-Claeyssens, Groupe Prophylaxie CoMETH, A Durin Assolant, P Lutz, Chantal Rothschild, Marc Trossaert, C. Guerois, Hervé Chambost, Annie Borel-Derlon, Claire Berger, G Dirat, Sandrine Meunier
Publikováno v:
Archives de Pédiatrie. 16:1571-1578
During the last decades, long-term prophylaxis has become the gold standard for the treatment of children with severe haemophilia A or B. Prophylactic replacement regimens modify the natural history of the disease by aiming at the prevention of haema
Publikováno v:
Haemophilia. 2:88-94
Summary. Using a binding assay to immobilized factor VIII (F VIII) (ELISA) we measured the amount of IgG with binding capacity to FVIII, in the plasma of patients with an inhibitor to F VIII, in multitransfused haemophiliacs without inhibitor and in
Autor:
Edith Fressinaud, M. E. Briquel, M. Alcalay, N. Stieltjes, J. Fonlupt, J.P. Cazenave, C. Guerois, Claude Negrier, A. Parquet, Roseline d'Oiron, J. Goudemand
Publikováno v:
Vox Sanguinis. 67:9-13
The prevalence of serum antibodies to hepatitis A virus (HAV) in 793 hemophilia A (HA) and 89 hemophilia B (HB) patients coming from 10 French Hemophilia Centers and treated since 1986-1987 with solvent/detergent (SD)-treated products is reported. Th
Publikováno v:
Revue Française de Transfusion et d'Hémobiologie. 36:417-426
Resume L'evolution de l'infection par le VIH a ete etudiee chez 480 hemophiles A et 78 hemophiles B traites dans la region Centre-Ouest. 23,3 % des hemophiles A et 46,1 % des hemophiles B ont ete contamines par le VIH. La prevalence de l'infection pa
Autor:
L. Bendelac, A. Parquet, Y. Laurian, Edith Fressinaud, A. Derlon, M.F. Aillaud, M.A. Bertrand, B. Boneu, F. Verroust, A.M. Berthier, Jeanne-Yvonne Borg, Marie-Francoise Torchet, C. Guerois, M. Fiks-Sigaud, E. Subtil
Publikováno v:
Vox Sanguinis. 64:210-214
The levels of anti-human and anti-porcine factor VIII inhibitors, measured in 63 severe haemophilia A patients, lay in the ranges of < 0.2-2,600 and < 0.2-1,300 Bethesda units per ml (BU/ml), respectively, with a median cross-reactivity of 33%. In 4
Autor:
Gérard Dirat, Marie F Torchet, Marie Elisabeth Briquel, Annie Borel-Derlon, Marie A Bertrand, C. Guerois, Thierry Lambert, Natalie Stieltjes, Laure Misrahi, Valérie Roussel-Robert
Publikováno v:
Blood coagulationfibrinolysis : an international journal in haemostasis and thrombosis. 20(1)
The physical condition of severe haemophilia and the impact of advances in replacement therapy have been much studied, but little work has been done on patients who developed inhibitors. The 'Statut Orthopedique des Patients Hemophiles avec Inhibiteu
Autor:
Thomas Sannié, C. Fondanesche, C. Guerois, S. Ayçaguer, Rémi Gagnayre, Thierry Lambert, N. Alliaume, A. Borel-Derlon, J. P. Bernhard, P. Guillon, Sandrine Meunier, Lydie Wintz, D. Valluet
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 16(3)
Summary. The activities of ‘expert patients’ or ‘patient tutors’, who help educate their peers, are gaining recognition in the health care system. This study investigates the role played by such patients in therapeutic education programmes or
Autor:
V. Roussel-Robert, A.M. Berthier, C. Guerois, Chantal Rothschild, Roseline d'Oiron, Fabienne Volot, Hervé Chambost, Alain Marques-Verdier, A. Borel-Derlon, A. Lienhart, Thierry Lambert, Kathelijne Peerlinck, J. Reynaud, J. Goudemand, Philippe Moreau
Publikováno v:
Seminars in hematology. 43(1 Suppl 1)
Patients with mild/moderate hemophilia A (MHA) may develop inhibitors to factor VIII (FVIII). In this condition, FVIII clotting activity (FVIII:C) baseline levels may remain stable for some patients, but may be reduced to less than 0.01 U/mL for othe
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 7(5)
We describe a young woman who developed acquired haemophilia after 18 months of interferon (IFN-)-alpha therapy. This patient had been monitored since 1992 for Hodgkin's disease initially treated by chemotherapy. After two relapses, she received inte
Autor:
Y, Gruel, C, Guerois
Publikováno v:
Gastroenterologie clinique et biologique. 22(6-7)